These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 2130683)
1. Immunology of Pseudomonas aeruginosa infection in cystic fibrosis. Høiby N; Pedersen SS; Jensen ET; Pressler T; Shand GH; Kharazmi A; Döring G Acta Univ Carol Med (Praha); 1990; 36(1-4):16-21. PubMed ID: 2130683 [TBL] [Abstract][Full Text] [Related]
2. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection. Kronborg G APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034 [TBL] [Abstract][Full Text] [Related]
3. Emergence and persistence of Pseudomonas aeruginosa in the cystic fibrosis airway. Fick RB; Sonoda F; Hornick DB Semin Respir Infect; 1992 Sep; 7(3):168-78. PubMed ID: 1475541 [TBL] [Abstract][Full Text] [Related]
4. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia. A new prophylactic principle. Johansen HK; Cryz SJ; Hougen HP; Moser C; Høiby N Behring Inst Mitt; 1997 Feb; (98):269-73. PubMed ID: 9382750 [TBL] [Abstract][Full Text] [Related]
5. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response. Ciofu O APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154 [TBL] [Abstract][Full Text] [Related]
7. Interaction between Pseudomonas aeruginosa and host defenses in cystic fibrosis. Marshall BC; Carroll KC Semin Respir Infect; 1991 Mar; 6(1):11-8. PubMed ID: 1909452 [TBL] [Abstract][Full Text] [Related]
8. Strategies of Pseudomonas aeruginosa to colonize and to persist in the cystic fibrosis lung. Kubesch P; Lingner M; Grothues D; Wehsling M; Tümmler B Scand J Gastroenterol Suppl; 1988; 143():77-80. PubMed ID: 3133755 [TBL] [Abstract][Full Text] [Related]
10. [Anti-Pseudomonas aeruginosa antibodies, circulating immune complexes, and anticytoplasm antibodies of neutrophils in patients with cystic fibrosis with and without Pseudomonas aeruginosa colonization]. Chiappini E; Taccetti G; Campana S; Turchini S; Marianelli L Pediatr Med Chir; 2001; 23(1):27-30. PubMed ID: 11486418 [TBL] [Abstract][Full Text] [Related]
11. Chronic Pseudomonas aeruginosa lung infection in normal and athymic rats. Johansen HK; Espersen F; Pedersen SS; Hougen HP; Rygaard J; Høiby N APMIS; 1993 Mar; 101(3):207-25. PubMed ID: 8507458 [TBL] [Abstract][Full Text] [Related]
12. Functional importance of cystic fibrosis immunoglobulin G fragments generated by Pseudomonas aeruginosa elastase. Bainbridge T; Fick RB J Lab Clin Med; 1989 Dec; 114(6):728-33. PubMed ID: 2512365 [TBL] [Abstract][Full Text] [Related]
13. [Pseudomonas aeruginosa antibodies in patients with cystic fibrosis: clinical implications]. Marianelli L; Campana S; Taccetti G; Gabbrielli M; Dei R Pediatr Med Chir; 1994; 16(6):551-4. PubMed ID: 7708538 [TBL] [Abstract][Full Text] [Related]
14. Rationale for development of immunotherapies that target mucoid Pseudomonas aeruginosa infection in cystic fibrosis patients. Pier GB Behring Inst Mitt; 1997 Feb; (98):350-60. PubMed ID: 9382760 [TBL] [Abstract][Full Text] [Related]
15. Induction of experimental chronic Pseudomonas aeruginosa lung infection with P. aeruginosa entrapped in alginate microspheres. Pedersen SS; Shand GH; Hansen BL; Hansen GN APMIS; 1990 Mar; 98(3):203-11. PubMed ID: 2107827 [TBL] [Abstract][Full Text] [Related]
16. Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients. Meluleni GJ; Grout M; Evans DJ; Pier GB J Immunol; 1995 Aug; 155(4):2029-38. PubMed ID: 7636254 [TBL] [Abstract][Full Text] [Related]
17. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients. Murray TS; Egan M; Kazmierczak BI Curr Opin Pediatr; 2007 Feb; 19(1):83-8. PubMed ID: 17224667 [TBL] [Abstract][Full Text] [Related]
18. Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses. Eichler I; Joris L; Hsu YP; Van Wye J; Bram R; Moss R J Clin Invest; 1989 Dec; 84(6):1794-804. PubMed ID: 2512330 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of serum antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis patients. Ratjen F; Walter H; Haug M; Meisner C; Grasemann H; Döring G Pediatr Pulmonol; 2007 Mar; 42(3):249-55. PubMed ID: 17243185 [TBL] [Abstract][Full Text] [Related]
20. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Bjarnsholt T; Jensen PØ; Fiandaca MJ; Pedersen J; Hansen CR; Andersen CB; Pressler T; Givskov M; Høiby N Pediatr Pulmonol; 2009 Jun; 44(6):547-58. PubMed ID: 19418571 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]